Personalis, Inc. Variable Lease, Cost
Personalis, Inc. (PSNL) reported Variable Lease, Cost of $801.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-04
- Personalis, Inc. variable lease, cost for the quarter ending 2026-06-30 was $801.00K, a 49.16% increase year-over-year.
- Personalis, Inc. variable lease, cost for the quarter ending 2026-03-31 was $705.00K, a 90.54% increase year-over-year.
- Personalis, Inc. variable lease, cost for the quarter ending 2025-12-31 was $820.00K, a 68.03% increase year-over-year.
- Personalis, Inc. variable lease, cost for the quarter ending 2025-09-30 was $537.00K, a 4.68% increase year-over-year.
- Personalis, Inc. variable lease, cost for fiscal 2025 was $2.26M, a 11.69% increase from fiscal 2024.
- Personalis, Inc. variable lease, cost for fiscal 2024 was $2.03M, a 10.89% increase from fiscal 2023.
- Personalis, Inc. variable lease, cost for fiscal 2023 was $1.83M, a 29.55% increase from fiscal 2022.
- Personalis, Inc. variable lease, cost for fiscal 2022 was $1.41M, a 22.48% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $801.00K 10-Q · filed 2026-08-04 | $1.51M 10-Q · filed 2026-08-04 | $2.33M derived: sum of 3 quarters · filed 2026-08-04 | $2.86M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $705.00K 10-Q · filed 2026-05-07 | $1.52M derived: sum of 2 quarters · filed 2026-05-07 | $2.06M derived: sum of 3 quarters · filed 2026-05-07 | $2.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $820.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.36M derived: sum of 2 quarters · filed 2026-02-26 | $1.89M derived: sum of 3 quarters · filed 2026-08-04 | $2.26M 10-K · filed 2026-02-26 |
| 2025-09-30 | $537.00K 10-Q · filed 2025-11-04 | $1.07M derived: sum of 2 quarters · filed 2026-08-04 | $1.44M 10-Q · filed 2025-11-04 | $1.93M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $537.00K 10-Q · filed 2026-08-04 | $907.00K 10-Q · filed 2026-08-04 | $1.40M derived: sum of 3 quarters · filed 2026-08-04 | $1.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $370.00K 10-Q · filed 2026-05-07 | $858.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.37M derived: sum of 3 quarters · filed 2026-05-07 | $2.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.00M derived: sum of 2 quarters · filed 2026-02-26 | $1.67M derived: sum of 3 quarters · filed 2026-02-26 | $2.03M 10-K · filed 2026-02-26 |
| 2024-09-30 | $513.00K 10-Q · filed 2025-11-04 | $1.18M derived: sum of 2 quarters · filed 2025-11-04 | $1.54M 10-Q · filed 2025-11-04 | $2.10M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $666.00K 10-Q · filed 2025-08-05 | $1.03M 10-Q · filed 2025-08-05 | $1.59M derived: sum of 3 quarters · filed 2025-08-05 | $1.97M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $360.00K 10-Q · filed 2025-05-06 | $924.00K derived: sum of 2 quarters · filed 2025-05-06 | $1.30M derived: sum of 3 quarters · filed 2025-05-06 | $1.70M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $945.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.33M derived: sum of 3 quarters · filed 2025-02-27 | $1.83M 10-K · filed 2025-02-27 |
| 2023-09-30 | $381.00K 10-Q · filed 2024-11-06 | $771.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.26M 10-Q · filed 2024-11-06 | $1.67M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $390.00K 10-Q · filed 2024-08-07 | $883.00K 10-Q · filed 2024-08-07 | $1.29M derived: sum of 3 quarters · filed 2024-08-07 | $1.65M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $493.00K 10-Q · filed 2024-05-08 | $901.00K derived: sum of 2 quarters · filed 2024-05-08 | $1.26M derived: sum of 3 quarters · filed 2024-05-08 | $1.64M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $765.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.15M derived: sum of 3 quarters · filed 2024-02-28 | $1.41M 10-K · filed 2024-02-28 |
| 2022-09-30 | $357.00K 10-Q · filed 2023-11-07 | $742.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.00M 10-Q · filed 2023-11-07 | $1.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $385.00K 10-Q · filed 2023-08-08 | $646.00K 10-Q · filed 2023-08-08 | $1.03M derived: sum of 3 quarters · filed 2024-02-28 | $1.40M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $261.00K 10-Q · filed 2023-05-03 | $650.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.02M derived: sum of 3 quarters · filed 2024-02-28 | $1.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $758.00K derived: sum of 2 quarters · filed 2024-02-28 | $923.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.15M 10-K · filed 2024-02-28 |
| 2021-09-30 | $369.00K 10-Q · filed 2022-11-02 | $534.00K derived: sum of 2 quarters · filed 2022-11-02 | $763.00K 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $165.00K 10-Q · filed 2022-08-03 | $394.00K 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $229.00K 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $748.00K 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $794.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |